Lymphoseek receives FDA approval for breast cancer, melanoma

[News]

The U.S. Food and Drug Administration today approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing surgery to remove tumor-draining lymph nodes.

More... (http://www.news-medical.net/news/20130314/Lymphoseek-receives-FDA-approval-for-breast-cancer-melanoma.aspx)